G
14.76
0.56 (3.94%)
Previous Close | 14.20 |
Open | 14.39 |
Volume | 575,073 |
Avg. Volume (3M) | 843,166 |
Market Cap | 458,284,736 |
Price / Sales | 4.18 |
Price / Book | 0.170 |
52 Weeks Range | |
Earnings Date | 13 Aug 2024 |
Operating Margin (TTM) | -689.26% |
Diluted EPS (TTM) | -87.00 |
Quarterly Revenue Growth (YOY) | 42.60% |
Total Debt/Equity (MRQ) | 2.82% |
Current Ratio (MRQ) | 11.55 |
Operating Cash Flow (TTM) | -665.49 M |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Bullish | Mixed |
Diagnostics & Research (Global) | Bullish | Mixed | |
Stock | GRAIL, Inc. | - | - |
Stockmoo Score
1.4
Analyst Consensus | 2.0 |
Insider Activity | -3.0 |
Price Volatility | 1.0 |
Technical Moving Averages | 5.0 |
Technical Oscillators | 2.0 |
Average | 1.40 |
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
% Held by Insiders | 14.67% |
% Held by Institutions | 78.35% |
Ownership
Name | Date | Shares Held |
---|---|---|
Sessa Capital Im, L.P. | 30 Jun 2024 | 2,450,000 |
Crcm Lp | 30 Jun 2024 | 952,784 |
No data within this time range.
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
CHASE WILLIAM J | 14.01 | - | 1,054 | 14,767 |
DING CHUN R | 12.93 | - | 16,200 | 209,466 |
MIZELL STEVEN | 14.01 | - | 978 | 13,702 |
RAGUSA ROBERT P | - | 14.01 | -123,454 | -1,729,591 |
SUMME GREGORY L | 14.01 | - | 1,656 | 23,201 |
Aggregate Net Quantity | -103,566 | |||
Aggregate Net Value ($) | -1,468,456 | |||
Aggregate Avg. Buy ($) | 13.74 | |||
Aggregate Avg. Sell ($) | 14.01 | |||
Insider Range ($) |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
RAGUSA ROBERT P | Officer | 15 Oct 2024 | Sell (-) | 123,454 | 14.01 | 1,729,591 |
CHASE WILLIAM J | Director | 15 Oct 2024 | Acquired (+) | 1,054 | 14.01 | 14,767 |
SUMME GREGORY L | Director | 15 Oct 2024 | Acquired (+) | 1,656 | 14.01 | 23,201 |
MIZELL STEVEN | Director | 15 Oct 2024 | Acquired (+) | 978 | 14.01 | 13,702 |
DING CHUN R | 09 Oct 2024 | Buy (+) | 16,200 | 12.93 | 209,466 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |